Factors associated with survival and mortality of people with covid-19 admitted to an intensive care unit
DOI:
https://doi.org/10.21527/2176-7114.2024.48.14336Keywords:
Intensive care units, Mortality, Survival, COVID-19Abstract
Introduction: Severe acute respiratory syndrome caused by coronavirus disease (COVID-19) spreads rapidly and has unstable behavior. Although most clinical manifestations of COVID-19 are asymptomatic or mild, there are severe forms that require admission to an Intensive Care Unit. Objective: to analyze the factors associated with survival and mortality of people with COVID-19 admitted to an intensive care unit. Method: This is a retrospective cohort study from March to August 2020, of people with COVID-19 admitted to the intensive care unit of a public hospital that is a reference for treating infectious diseases in the State of Ceará, Brazil. The survival probability was determined using Kaplan Meier, with survival calculations using the R version 3.2 software and comparison between survival curves. A significance level of p=0.05 was considered. Results: Of the 92 people with COVID-19, 66.3% were men, obese (23.38%), with cardiovascular disease (19.48%) and HIV (19.48%). A statistically significant difference (p=0.03) was observed with hypertension. The average survival time was 33.93. Mortality from COVID-19 was 69.6%. Conclusion: The chance of survival was greater in women. Older age, male sex, obesity and hypertension were associated with a higher risk of death. The results of this study can help managers and healthcare professionals identify high-risk groups that should receive invasive interventions and supportive care.
References
World Health Organization - WHO. [2020a]. Coronavirus disease. Disponível em: https://www.who.int/ith/ diseases/sars/en/; https://www.who.int/emergencies/mers-cov/en/]
World Health Organization - WHO. Coronavirus disease 2019 (COVID-19) – WHO Coronavirus Disease (COVID-19) dashboard [Internet]. Geneve: WHO; 2020 [cited 2022 Sep 9]. Available from: https://covid19.who.int/
Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care Units in Lombardy, Italy. Jama Intern Med [Internet]. 2020 Jul [cited 2022 Nov 3];180(10):1345-55. Available from: https://doi.org/10.1001/jamainternmed.2020.3539
Lippi G, Henry BM, Sanchis-Gomar F. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19). Eur J Prev Cardiol. 2020 Jun;27(9):906-908. doi: 10.1177/2047487320916823
Zhang, Zhu N, Zhang D, Wang W, Li X, Yang B, et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24
Kaeuffer C, Le Hyaric C, Fabacher T, Mootien J, Dervieux B, Ruch Y, et al. Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020. Euro Surveill. 2020 Dec;25(48):2000895. doi: 10.2807/1560-7917.ES.2020.25.48.2000895
Davenne, E, Giot JB, Huynen P. Coronavirus et COVID-19: le point sur une pandémie galopante. Rev Med Liege. 2020 Abr; 75(4): 218-225. https://pubmed.ncbi.nlm.nih.gov/32267109/
, Governo do Estado do Ceará. Secretaria de Saúde do Ceará. IntegraSUS [Internet]. Cited: 24 abr 2020. Available from: https://integrasus.saude.ce.gov.br/#/area/1
Nappi C, Megna R, Acampa W, Assante R, Zampella E, Gaudieri V, et al. Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):421-427. doi: 10.1007/s00259-020-04994-6
Maganga GD, Pinto A, Mombo IM, Madjitobaye M, Mbeang Beyeme AM, Boundenga L, et al. Genetic diversity and ecology of coronaviruses hosted by cave-dwelling bats in Gabon. Sci Rep. 2020 Apr 30;10(1):7314. doi: 10.1038/s41598-020-64159-1
Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis. J Med Virol. 2020 Jun;92(6):612-617. doi: 10.1002/jmv.25735
Channappanavar R, Perlman, infecções por coronavírus humanos S. Pathogenic: causas e consequências da tempestade de citocinas e imunopatologia. Semin Immunopathol, 39, 529–539 (2017). https://doi.org/10.1007/s00281-017-0629-x
Agrawal H, Das N, Nathani S, Saha S, Saini S, Kakar SS, Roy P. (2020). An assessment on impact of COVID-19 infection in a gender specific manner. Stem cell reviews and reports, 1-19. doi: 10.1007/s12015-020-10048-z
Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, et al. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect. 2020 Aug;26(8):1063-1068. doi: 10.1016/j.cmi.2020.03.032
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 Feb [cited 2022 Nov 3]; 395(10223):497-506.Available from: https://doi.org/10.1016/S0140-6736(20)30183-5
Teich VD, Klajner S, Almeida FAS, Dantas ACB, Laselva CR, Torritesi MG, et al. Epidemiologic and clinical features of patients with COVID-19 in Brazil. Einstein (Sao Paulo). 2020;18:eAO6022. doi: 10.31744/einstein_journal/2020ao6022
Goldman JD, Wang K, Roltgen K, Nielsen SCA, Roach JC, Naccache SN, et al. Reinfecção com SARS-CoV-2 e Falha de Imunidade Humoral: relato de caso. medRxiv [Pré-impressão] . 25 de setembro de 2020.09.22.20192443. doi: 10.1101 / 2020.09.22.2019244
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinicalcourse and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospectivecohort study. Lancet [Internet]. 2020 Mar [cited 2020 Nov 3];395(10229):1054-62. Available from: https://doi.org/10.1016/S0140-6736(20)30566-3
Hoffmann M, Kleine-Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. 2020. doi: https://doi.org/10.1101/2020.01.31.929042
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Contexto & Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
Autores que publicam na Revista Contexto & Saúde concordam com os seguintes termos:
a) A submissão de trabalho(s) científico(s) original(is) pelos autores, na qualidade de titulares do direito de autor do(s) texto(s) enviado(s) ao periódico, nos termos da Lei 9.610/98, implica na cessão de direitos autorais de publicação na Revista Contexto e Saúde do(s) artigo(s) aceitos para publicação à Universidade Regional do Noroeste do Estado do Rio Grande do Sul, autorizando-se, ainda, que o(s) trabalho(s) científico(s) aprovado(s) seja(m) divulgado(s) gratuitamente, sem qualquer tipo de ressarcimento a título de direitos autorais, por meio do site da revista e suas bases de dados de indexação e repositórios, para fins de leitura, impressão e/ou download do arquivo do texto, a partir da data de aceitação para fins de publicação. Isto significa que, ao procederem a submissão do(s) artigo(s) à Revista Contexto e Saúde e, por conseguinte, a cessão gratuita dos direitos autorais relacionados ao trabalho científico enviado, os autores têm plena ciência de que não serão remunerados pela publicação do(s) artigo(s) no periódico.
b). Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
c). Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
d. Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado (Veja O Efeito do Acesso Livre).
